Status:
COMPLETED
Dafilon® Suture Material in Patients Undergoing Ophthalmic Surgery
Lead Sponsor:
Aesculap AG
Collaborating Sponsors:
B.Braun Surgical SA
Conditions:
Eye Diseases
Eligibility:
All Genders
Brief Summary
This is an observational, retrospective postmarket clinical follow-up study and includes all patients who underwent any ophthalmic surgery using Dafilon® suture in the selected centres between 2018 an...
Eligibility Criteria
Inclusion
- Patient operated between 2018 - 2020 undergoing any ophthalmic surgery using Dafilon® suture material (Dafilon® USP (United States Pharmacopeia) sizes from 8/0 to 11/0) at the participating hospital
Exclusion
- No exclusion criteria have been set
Key Trial Info
Start Date :
January 8 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 10 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05968443
Start Date
January 8 2019
End Date
May 10 2022
Last Update
August 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KPJ Tawakkal KL Specialist Hospital
Kuala Lumpur, Kuala Lumpur, Malaysia, 53000